FHTX stock news · Foghorn Therapeutics
Get alerts for FHTX
Follow Foghorn Therapeutics (FHTX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for FHTXOn Friday, 12 health care stocks changed a lot in price during the day.
NeutralFoghorn Therapeutics' shares fell 23.26% during Friday's session. The article gives no company news behind the drop, so it does not change the business outlook.
On Thursday, 12 health care stocks saw big price changes, with Nexalin Technology jumping up 77.8%.
NeutralFoghorn Therapeutics shares fell 24.37% during Thursday's session, but the article gives no company news explaining the drop, so its business outlook is unchanged.
Foghorn Therapeutics is changing its plans after ending its partnership with Eli Lilly.
Bad for FHTXFoghorn is ending Lilly-linked drug work and focusing on its own research. Animal results and longer cash support help, but the stopped programs make this unfavorable.
12 health care stocks are changing a lot before the market opens on Thursday.
NeutralFoghorn Therapeutics shares fell 47.9%. The article gives no business news to explain the drop or change the company's outlook.
Foghorn Therapeutics Inc. says it will spend money to close down some operations.
Bad for FHTXFoghorn will stop expanding its FHD-909 trial with Lilly and cut about 40% of its staff. This is negative for Foghorn despite its focus on other programs.